drugset / Trial / NCT00025571
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer
Treatment
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make tumor cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by tumor cells and, when exposed to light, become active and kill the tumor cells. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have non-small cell lung cancer.
Timeline
- Start
- 2001-06
- Primary completion
- 2002-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A | Unknown | — | Intravenous |